cells <1%–20%) and highly aggressive NEC, general guidelines for diagnostic workup and subsequent therapy are largely missing in the group neuroendocrine tumors G3 (Ki67 pos. This evidence concerns the gene MKI67 and neuroendocrine carcinoma.